MARSTACIMAB-HNCQ: 13 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
13
Total FAERS Reports
0
Deaths Reported
1
Hospitalizations
13
As Primary/Secondary Suspect
Prescription
Status
FDA Application: 761369 ·
First Report: 20250101 · Latest Report: 20250701
What Are the Most Common MARSTACIMAB-HNCQ Side Effects?
#1 Most Reported
Haemarthrosis
5 reports (38.5%)
#2 Most Reported
Product dose omission issue
2 reports (15.4%)
#3 Most Reported
Epistaxis
2 reports (15.4%)
All MARSTACIMAB-HNCQ Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Haemarthrosis | 5 | 38.5% | 0 | 0 |
Who Reports MARSTACIMAB-HNCQ Side Effects? Age & Gender Data
Gender: 8.3% female, 91.7% male. Average age: 35.5 years. Most reports from: US. View detailed demographics →
Is MARSTACIMAB-HNCQ Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2025 | 4 | 0 | 0 |
Official FDA Label for MARSTACIMAB-HNCQ
Official prescribing information from the FDA-approved drug label.